Published in Am J Manag Care on May 01, 2008
Preventive screening of women who use complementary and alternative medicine providers. J Womens Health (Larchmt) (2009) 1.56
The association of depression and pain with health-related quality of life, disability, and health care use in cancer patients. J Pain Symptom Manage (2010) 1.12
Identification of ovarian cancer symptoms in health insurance claims data. J Womens Health (Larchmt) (2010) 0.91
Complementary and alternative medicine use among US cancer survivors. J Cancer Surviv (2016) 0.84
Complementary and alternative medicine use by breast cancer patients at time of surgery which increases the potential for excessive bleeding. Integr Cancer Ther (2014) 0.76
Complementary and alternative medicine in cancer care. Am J Manag Care (2008) 0.75
Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med (1993) 28.86
German Acupuncture Trials (GERAC) for chronic low back pain: randomized, multicenter, blinded, parallel-group trial with 3 groups. Arch Intern Med (2007) 7.21
Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee: a randomized, controlled trial. Ann Intern Med (2004) 5.69
The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev (1999) 5.49
Varieties of healing. 2: a taxonomy of unconventional healing practices. Ann Intern Med (2001) 3.42
Patient time costs associated with cancer care. J Natl Cancer Inst (2007) 2.90
Deaths: preliminary data for 2004. Natl Vital Stat Rep (2006) 2.52
Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med (2002) 2.29
A review of the evidence for the effectiveness, safety, and cost of acupuncture, massage therapy, and spinal manipulation for back pain. Ann Intern Med (2003) 2.25
Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev (2006) 2.03
Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs. J Altern Complement Med (2002) 1.85
The effect of mandating complementary and alternative medicine services on insurance benefits in Washington State. J Altern Complement Med (2004) 1.74
Costs of cancer care in the USA: a descriptive review. Nat Clin Pract Oncol (2007) 1.54
Complementary and alternative medicine use among health plan members. A cross-sectional survey. Eff Clin Pract (2002) 1.39
The role of alternative medical providers for the outpatient treatment of insured patients with back pain. Spine (Phila Pa 1976) (2005) 1.27
Analysis of the National Institutes of Health Medicare coverage assessment. Int J Technol Assess Health Care (1990) 1.23
Challenges of using medical insurance claims data for utilization analysis. Am J Med Qual (2006) 1.19
Insurance coverage and subsequent utilization of complementary and alternative medicine providers. Am J Manag Care (2006) 1.19
Off-label or out of bounds? Prescriber and marketer liability for unapproved uses of FDA-approved drugs. Ann Health Law (2003) 1.18
Health care workforce for the twenty-first century: the impact of nonphysician clinicians. Annu Rev Med (2001) 1.15
Prevalence of lumbar facet arthrosis and its relationship to age, sex, and race: an anatomic study of cadaveric specimens. Spine (Phila Pa 1976) (2007) 1.14
The use of complementary and alternative medical providers by insured cancer patients in Washington State. Cancer (2004) 1.14
Evaluating CAM treatment at the end of life: a review of clinical trials for massage and meditation. Complement Ther Med (2006) 0.92
Frequency of low back pain among men and women aged 30 to 64 years in France. Results of two national surveys. Ann Readapt Med Phys (2007) 0.91
Evidence report on the treatment of pain in cancer patients. J Natl Cancer Inst Monogr (2004) 0.87
Urban/rural differences in decision making and the use of advance directives among nursing home residents at admission. J Rural Health (2004) 0.83
Managed care market share and primary treatment for cancer. Health Serv Res (2006) 0.81
Merging claims databases with a tumor registry to evaluate variations in cancer mortality: results from a pilot study of 698 colorectal cancer patients treated at one hospital in the 1990s. Cancer Invest (2004) 0.80
Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer (2007) 4.76
Nine-year prospective relationship between parental smoking cessation and children's daily smoking. Addiction (2003) 3.14
Quality of life in long term survivors of colorectal cancer. Am J Gastroenterol (2002) 1.84
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood (2012) 1.81
Comparison of health care expenditures among insured users and nonusers of complementary and alternative medicine in Washington State: a cost minimization analysis. J Altern Complement Med (2010) 1.58
Preventive screening of women who use complementary and alternative medicine providers. J Womens Health (Larchmt) (2009) 1.56
Regional variations in early and late survival after out-of-hospital cardiac arrest. Resuscitation (2012) 1.55
Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.52
Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant. Leuk Lymphoma (2014) 1.50
Prospective prediction of children's smoking transitions: role of parents' and older siblings' smoking. Addiction (2006) 1.49
Efficacy of hypomethylating agents in therapy-related myelodysplastic syndromes. Leuk Res (2012) 1.47
Nine-year prediction of adolescent smoking by number of smoking parents. Addict Behav (2005) 1.32
The role of alternative medical providers for the outpatient treatment of insured patients with back pain. Spine (Phila Pa 1976) (2005) 1.27
Insurance coverage and subsequent utilization of complementary and alternative medicine providers. Am J Manag Care (2006) 1.19
Childhood friends who smoke: do they influence adolescents to make smoking transitions? Addict Behav (2005) 1.18
Potential interactions between complementary/alternative products and conventional medicines in a Medicare population. Ann Pharmacother (2007) 1.17
Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125. Cancer Epidemiol Biomarkers Prev (2009) 1.16
Quality of life at the end of life. Health Qual Life Outcomes (2007) 1.14
The relationship between perceived risk, affect, and health behaviors. Cancer Detect Prev (2004) 1.11
Changes in the influence of parents' and close friends' smoking on adolescent smoking transitions. Addict Behav (2006) 1.10
Parents' and older siblings' smoking during childhood: changing influences on smoking acquisition and escalation over the course of adolescence. Nicotine Tob Res (2007) 1.10
Effectiveness of telephone counseling for mammography: results from five randomized trials. Prev Med (2002) 1.08
Breast cancer risk counseling improves women's functioning. Patient Educ Couns (2004) 1.06
Maternal work and birth outcome disparities. Matern Child Health J (2007) 1.06
Complementary and alternative provider use by insured patients with diabetes in Washington State. J Altern Complement Med (2006) 1.02
Optimism, perceived risk of breast cancer, and cancer worry among a community-based sample of women. Health Psychol (2004) 1.01
Frequency, predictors, and expenditures for pediatric insurance claims for complementary and alternative medical professionals in Washington State. Arch Pediatr Adolesc Med (2005) 0.99
Nine-year prospective association between older siblings' smoking and children's daily smoking. J Adolesc Health (2003) 0.99
Psychological and social risk factors in adolescent smoking transitions: a population-based longitudinal study. Health Psychol (2009) 0.97
Chiropractic use by urban and rural residents with insurance coverage. J Rural Health (2009) 0.95
The role of schoolmates' smoking and non-smoking in adolescents' smoking transitions: a longitudinal study. Addiction (2007) 0.95
Does parental smoking cessation encourage their young adult children to quit smoking? A prospective study. Addiction (2005) 0.93
Use of complementary and alternative medicine providers by fibromyalgia patients under insurance coverage. Arthritis Rheum (2007) 0.92
Identification of ovarian cancer symptoms in health insurance claims data. J Womens Health (Larchmt) (2010) 0.91
Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability. Gynecol Oncol (2011) 0.88
Pediatric vaccination and vaccine-preventable disease acquisition: associations with care by complementary and alternative medicine providers. Matern Child Health J (2010) 0.87
The effect of complementary and alternative medicine claims on risk adjustment. Med Care (2006) 0.86
Recruiting patients with breast cancer and their families to behavioral research in the post-HIPAA period. Oncol Nurs Forum (2007) 0.82
Costs and cost-effectiveness of a clinical intervention to increase mammography utilization in an inner city public health hospital. Prev Med (2002) 0.82
Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant. Leuk Lymphoma (2014) 0.81
Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening. Cancer Epidemiol Biomarkers Prev (2004) 0.81
The temporal stability of the Symptom Index among women at high-risk for ovarian cancer. Gynecol Oncol (2009) 0.79
Addressing the challenges of obtaining functional outcomes in traumatic brain injury research: missing data patterns, timing of follow-up, and three prognostic models. J Neurotrauma (2014) 0.78
Adverse events associated with complementary and alternative medicine use in ovarian cancer patients. Integr Cancer Ther (2013) 0.75
Can we demonstrate that breast cancer "integrative oncology" is effective? A methodology to evaluate the effectiveness of integrative oncology offered in community clinics. Integr Cancer Ther (2012) 0.75
Symptoms of breast cancer in an age of technologic screening. J Womens Health (Larchmt) (2011) 0.75
Much ado about mammography variability. J Natl Cancer Inst (2002) 0.75
Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat Med (2017) 0.75